Completed

Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Regular non-hydrolysed cow's milk I

+ Regular non-hydrolysed cow's milk II

+ Regular non-hydrolysed cow's milk - control

Other
Who is being recruted

See all eligibility criteria
How is the trial designed

Other Study

Placebo-Controlled
Interventional
Study Start: May 2013
See protocol details

Summary

Principal SponsorDanone Asia Pacific Holdings Pte, Ltd.
Last updated: September 7, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2013

Actual date on which the first participant was enrolled.

This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.

Principal SponsorDanone Asia Pacific Holdings Pte, Ltd.
Last updated: September 7, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

290 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

Inclusion Criteria: Healthy term infants (gestational age ≥ 37 1/7 and ≤ 41 6/7 weeks) aged 46 - 65 days (inclusive) at entry into the study Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study) Parents' or legal guardian's written informed consent Exclusion Criteria: Exclusion criteria for run-in period (visit 1, screening) are: Being weaned before inclusion (introduction of any other foods other than formula or human milk) Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards Medical condition for which a special diet other than standard (non hydrolised) cow's milk-based infant formula is required Known congenital diseases or malformations which could interfere with the study (e.g. gastrointestinal malformations, congenital immunodeficiency), as per investigator's clinical judgement Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks prior to entry into the study Received Inactivated Poliovirus Vaccine (IPV) or Rotavirus Vaccine (RV) prior to entry into the study Gastroenteritis or diarrhoea in the last two weeks prior to entry into the study Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

4 intervention groups are designated in this study

25% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I

Group II

Active Comparator
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II

Group III

Placebo
Regular non-hydrolysed cow's milk based infant formula

Group IV

No Intervention
Exclusively breast-fed infants

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Thammasat Hospital

Klong Luang, ThailandOpen Thammasat Hospital in Google Maps

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

Phramongkutklao Hospital

Bangkok, Thailand
Completed3 Study Centers